On January 27, the medical AI application "Hydrogen Ion" under Alibaba Health released a major update, officially launching the **"Dynamic Evidence Localization"** feature.
The core of this feature is to upgrade traditional "static references" into **"living evidence."** To address the issue of AI-generated false information (hallucinations) in clinical and research settings, the new system can not only accurately locate original sentences but also simultaneously verify the timeliness, authority, and logical consistency of the information.
Based on its unique "Three-Dimensional Evidence-Based Architecture," Hydrogen Ion tracks global medical guidelines and literature on a daily basis. When doctors query complex clinical data (such as the endpoints of the Erdafitinib trial), the system can directly mark clickable reference tags, supporting seamless traceability from conclusions to original literature. The product manager stated that this move aims to achieve professional standards for medical AI by precisely extracting key sentences and dynamically filtering weights, making the AI truly "verifiable, trustworthy, and usable."
